BackVivani Medical- Warrants (14/03/2024) Overview

Vivani Medical- Warrants (14/03/2024) Long Term Debt

Track Vivani Medical- Warrants (14/03/2024)'s long-term debt ($16M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$16.01M
53.66% YoYΔ $-18.55M vs prior year quarter

Peer trimmed avg / median

Loading

Vivani Medical- Warrants (14/03/2024) Long Term Debt History

Loading

Vivani Medical- Warrants (14/03/2024) vs. peers: Long Term Debt Comparison

Loading

Vivani Medical- Warrants (14/03/2024) Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vivani Medical- Warrants (14/03/2024) (VANIW) FAQ

Vivani Medical- Warrants (14/03/2024) (VANIW) currently reports a long-term debt of $16M as of June 2026. That compares with $35M in the prior-year period — down 53.7% year over year. Use the charts on this page to explore Vivani Medical- Warrants (14/03/2024)'s long-term debt history and peer comparisons.

Vivani Medical- Warrants (14/03/2024)'s long-term debt decreased from $35M to $16M — a 53.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vivani Medical- Warrants (14/03/2024) reported $16M in long-term debt as of June 2026. That compares with $35M in the prior-year period — down 53.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vivani Medical- Warrants (14/03/2024), and consider following VANIW for alerts when major investors trade the stock.

Vivani Medical- Warrants (14/03/2024) is classified in the Healthcare sector. On long-term debt, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VANIW with unrelated industries.